Pharma Equity Group A/S (CHIX:PEGC) Total Stockholders Equity : kr38.93 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharma Equity Group A/S Total Stockholders Equity?

Pharma Equity Group A/S's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr38.93 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pharma Equity Group A/S's Book Value per Share for the quarter that ended in Dec. 2023 was kr0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pharma Equity Group A/S's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.78.

Pharma Equity Group A/S Total Stockholders Equity Historical Data

The historical data trend for Pharma Equity Group A/S's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Total Stockholders Equity Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

67.16

34.28

42.57

46.05

38.93

Pharma Equity Group A/S Quarterly Data
	Mar16	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															46.05	61.38	55.92	51.27	38.93

Pharma Equity Group A/S (CHIX:PEGc) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pharma Equity Group A/S's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(38.931	-	0)	/	1022.95
	=	0.04

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pharma Equity Group A/S's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(22.149	+	8.072)	/	38.931
	=	0.78

Pharma Equity Group A/S Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (CHIX:PEGC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (CHIX:PEGc) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PEG:Denmark

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.

Pharma Equity Group A/S (CHIX:PEGC) Headlines

No Headlines